Co-infection and Cancer (R01 Clinical Trial Not Allowed) (344903)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: May 5, 2023 (Letter of inquiry)

Later deadlines: Jun 5, 2023 (Full proposal), Jan 5, 2024 (Letter of inquiry), Feb 5, 2024 (Full proposal), May 5, 2024 (Letter of inquiry), Jun 5, 2024 (Full proposal), Sep 5, 2024 (Letter of inquiry), Sep 5, 2024 (Letter of inquiry), Oct 5, 2024 (Full proposal), Oct 5, 2024 (Full proposal), Jan 5, 2025, Feb 5, 2025 (Full proposal), May 5, 2025 (Letter of inquiry), Jun 5, 2025 (Full proposal), Sep 5, 2025 (Letter of inquiry), Oct 5, 2025 (Full proposal)

Grant amount: Unspecified amount

Fields of work: Cancer/Oncology

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world


NOTE: All applications are due by 5:00 PM local time of applicant organization. 

This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to co-infections (excluding co-infection with human immunodeficiency virus [HIV]) that engendered novel opportunities for prevention and treatment and focus on understudied populations. Coinfection is defined as the occurrence of infections by two or more infectious (pathogenic or nonpathogenic) agents either concurrently or sequentially and includes both acute and chronic infections by viruses, bacteria, parasites, and/or other microorganisms.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed December 16, 2022 and last updated December 16, 2022